SCHEMBL24716152

SCHEMBL24716152

O=[N+]([O-])c1cc(Cl)c2c(OCCF)ccnc2c1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.57
KMT2A Q03164 7/20 0.57
MAPT P10636 6/20 0.57
MEN1 O00255 6/20 0.57
TDP1 Q9NUW8 5/20 0.57
L3MBTL1 Q9Y468 5/20 0.57
HTT P42858 4/20 0.57
PKM P14618 3/20 0.57
SMN1; SMN2 Q16637 3/20 0.57
LMNA P02545 3/20 0.57
ALDH1A1 P00352 7/20 0.51
HSP90AA1 P07900 2/20 0.51
OPRK1 P41145 1/20 0.51
GAA P10253 3/20 0.49
IDO1 P14902 2/20 0.49
TDO2 P48775 2/20 0.49
CTSB P07858 2/20 0.49
POLB P06746 3/20 0.48
RECQL P46063 3/20 0.48
BLM P54132 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24715768 0.86 MAPT (0.60) KDM4EKMT2AMAPTMEN1TDP1
SCHEMBL24715898 0.83 KDM4E (0.62) KDM4EKMT2AMAPTMEN1TDP1
SCHEMBL24716064 0.83 KDM4E (0.56) KDM4EKMT2AMAPTMEN1TDP1
SCHEMBL24715849 0.83 KMT2A (0.56) KDM4EKMT2AMAPTMEN1TDP1
SCHEMBL24716062 0.80 MEN1 (0.58) KDM4EKMT2AMAPTMEN1TDP1
SCHEMBL24716142 0.80 KDM4E (0.72) KDM4EKMT2AMAPTMEN1TDP1
SCHEMBL24715870 0.79 MAPT (0.67) KDM4EKMT2AMAPTMEN1TDP1
SCHEMBL24715848 0.77 KDM4E (0.55) KDM4EKMT2AMAPTMEN1TDP1
SCHEMBL24716621 0.76 KDM4E (0.54) KDM4EKMT2AMAPTMEN1TDP1
SCHEMBL27190077 0.76 MAPT (0.62) KDM4EKMT2AMAPTMEN1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4623914-A1 USE OF 8-HYDROXYQUINOLINE DERIVATIVE Jiangsu Yahong Meditech Co., Ltd. (CN) 2025-10-01 EP disclosed
CN-120035438-A Use of 8-hydroxyquinoline derivatives 江苏亚虹医药科技股份有限公司 2025-05-23 CN disclosed
US-20240246916-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVES, PREPARATION METHOD THEREFORE AND MEDICAL USE THEREOF JIANGSU YAHONG MEDITECH CO., LTD. (CN) 2024-07-25 US disclosed
WO-2024109684-A1 USE OF 8-HYDROXYQUINOLINE DERIVATIVE 江苏亚虹医药科技股份有限公司 2024-05-30 WO disclosed
CN-118059101-A Use of 8-hydroxyquinoline derivatives 江苏亚虹医药科技股份有限公司 2024-05-24 CN disclosed
EP-4349815-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF Jiangsu Yahong Meditech Co., Ltd. (CN) 2024-04-10 EP disclosed
CN-117043141-A 7-nitro-8-hydroxyquinoline derivative, preparation method and medical application thereof 江苏亚虹医药科技股份有限公司 2023-11-10 CN disclosed
WO-2022253152-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 江苏亚虹医药科技股份有限公司 2022-12-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240246916-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVES, PREPARATION METHOD THEREFORE AND MEDICAL USE THEREOF CYP3A7, UGT1A7, UGT2B7 KDM4E 2921/4885KMT2A 2738/4885MAPT 4416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.